Plasminogen activator inhibitor-1 free fatty acids, and insulin resistance in patients with myocardial infarction

被引:10
作者
Gruzdeva, Olga [1 ]
Uchasova, Evgenya [1 ]
Dyleva, Yulia [1 ]
Belik, Ekaterina [1 ]
Shurygina, Ekaterina [1 ]
Barbarash, Olga [1 ]
机构
[1] Russian Acad Med Sci, Res Inst Complex Issues Cardiovasc Dis, Siberian Branch, Kemerovo, Russia
关键词
free fatty acids; type 2 diabetes mellitus; myocardial infarction; insulin resistance; plasminogen activator inhibitor 1;
D O I
10.2147/DMSO.S46627
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Insulin resistance is known to be a common feature of type 2 diabetes mellitus and is regarded as an important mechanism in the pathogenesis of this disease. The key pathogenetic mechanisms of insulin resistance progression are free fatty acids metabolism impairment and enhanced activity of plasminogen activator inhibitor 1. Both free fatty acids and plasminogen activator inhibitor 1 are recognized as risk factors for coronary heart disease. Methods: The patients were divided into two groups: group 1 included 65 non-diabetic myocardial infarction patients and group 2 enrolled 60 diabetic myocardial infarction patients. The control group consisted of 30 sex-and age-matched volunteers. The concentration of serum free fatty acids, glucose, C-peptide, and insulin were measured on the 1st and 12th days of the study. All the patients had their postprandial glycemia, insulin, and C-peptide concentrations measured 2 hours after a standard carbohydrate breakfast containing 360 kcal ( protein 20g, carbohydrate 57g, and fat 9g). Results: Free fatty acids levels in group 1 and in group 2 exceeded the control group values by 7-fold and 11-fold, respectively. Plasminogen activator inhibitor 1 concentration was 2.5-fold higher in group 1 and 4.6-fold higher in group 2 compared to the control group on the 1st day from the myocardial infarction onset. In addition, plasminogen activator inhibitor 1 concentration was significantly reduced in both groups on the 12th day from the myocardial infarction onset; however, it did not achieve the control group values. Conclusion: Increased postprandial glucose level, insulinemia, and elevated levels of free fatty acids and plasminogen activator inhibitor are associated with myocardial infarction-associated progression of insulin resistance. However, insulin resistance metabolic markers are of great predictive capacity in the assessment of risk of acute coronary events.
引用
收藏
页码:293 / 301
页数:9
相关论文
共 15 条
[1]   PAI-1 and the metabolic syndrome - Links, causes, and consequences [J].
Alessi, Marie-Christine ;
Juhan-Vague, Irene .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (10) :2200-2207
[2]   Antidiabetic drugs present and future: Will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus? [J].
Campbell, IW .
DRUGS, 2000, 60 (05) :1017-1028
[3]   Insulin resistance: Cellular and clinical concepts [J].
Cefalu, WT .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 226 (01) :13-26
[4]   Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality [J].
Collet, JP ;
Montalescot, G ;
Vicaut, E ;
Ankri, A ;
Walylo, F ;
Lesty, C ;
Choussat, R ;
Beygui, F ;
Borentain, M ;
Vignolles, N ;
Thomas, D .
CIRCULATION, 2003, 108 (04) :391-394
[5]   Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies [J].
Huxley, R ;
Barzi, F ;
Woodward, M .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7533) :73-76
[6]   Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era [J].
Ishihara, M ;
Kojima, S ;
Sakamoto, T ;
Asada, Y ;
Tei, C ;
Kimura, K ;
Miyazaki, S ;
Sonoda, M ;
Tsuchihashi, K ;
Yamagishi, M ;
Ikeda, Y ;
Shirai, M ;
Hiraoka, H ;
Inoue, T ;
Saito, F ;
Ogawa, H .
AMERICAN HEART JOURNAL, 2005, 150 (04) :814-820
[7]   The plasminogen activator inhibitor-1-675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study [J].
Juhan-Vague, I ;
Morange, PE ;
Frere, C ;
Aillaud, MF ;
Alessi, MC ;
Hawe, E ;
Boquist, S ;
Tornvall, P ;
Yudkin, JS ;
Tremoli, E ;
Margaglione, M ;
Di Minno, G ;
Hamsten, A ;
Humphries, SE .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (11) :2322-2329
[8]   Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans [J].
Katz, A ;
Nambi, SS ;
Mather, K ;
Baron, AD ;
Follmann, DA ;
Sullivan, G ;
Quon, MJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2402-2410
[9]  
Kryzhanovsky VA, 2001, DIAGNOSIS TREATMENT
[10]   Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences [J].
Leclercq, Isabelle A. ;
Morais, Alain Da Silva ;
Schroyen, Ben ;
Van Hul, Noml ;
Geerts, Albert .
JOURNAL OF HEPATOLOGY, 2007, 47 (01) :142-156